Literature DB >> 7801516

Brucella abortus cytoplasmic proteins used as antigens in an ELISA potentially useful for the diagnosis of canine brucellosis.

P C Baldi1, M M Wanke, M E Loza, C A Fossati.   

Abstract

A preparation of Brucella abortus cytoplasmic proteins was depleted of lipopolysaccharide (LPS) by immunoadsorption with a monoclonal antibody (BC68) specific for the O antigen of B. abortus smooth LPS. This extract was used as antigen in an indirect ELISA for measuring antiprotein humoral immune response in dogs suffering from brucellosis and in healthy controls. All of the affected dogs studied showed IgG antiprotein response, while 2% (2 of 103) of the healthy dogs used as controls gave a positive result. All sera found to be positive by ELISA were also positive by the rapid slide agglutination test. These preliminary results show that the ELISA using B. abortus cytoplasmic proteins could be useful for the specific diagnosis of canine brucellosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7801516     DOI: 10.1016/0378-1135(94)90142-2

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  Enzymatic and biological characteristics of enolase in Brucella abortus A19.

Authors:  Xiangan Han; Chan Ding; Hongjun Chen; Qinghai Hu; Shengqing Yu
Journal:  Mol Biol Rep       Date:  2011-06-15       Impact factor: 2.316

2.  Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis.

Authors:  P C Baldi; G F Araj; G C Racaro; J C Wallach; C A Fossati
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

3.  Comparison of BP26, Omp25 and Omp31 and a Multiepitope-Based Fusion Protein in the Serological Detection of Canine Brucellosis.

Authors:  Meixue Yao; Mengda Liu; Xia Chen; Jianjun Li; Yan Li; Yu Run Wei; Yong Liu; Kang Long Yang; Xiaoxiao Duan; Weixing Shao; Xiangxiang Sun; Xiaoxu Fan; Shufang Sun; Lili Tian; Dehui Yin; Mingjun Sun
Journal:  Infect Drug Resist       Date:  2022-09-07       Impact factor: 4.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.